Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Healios KK Ord Shs HLOSF

HEALIOS K.K. is a Japan-based company mainly engaged in research and development of pharmaceutical products. The Company has compound pharmaceutical products line and induced pluripotent stem cell (iPSC) regenerative medicine product line. The compound pharmaceutical product line contains HLM0021, HLM0022 and HLM0023. The products are ophthalmological surgery adjuvants, mainly contain brilliant blue G-250 (BBG250) which help capsule temporarily safely stained to protect the inner limiting membranes and lens during surgery of vitreous and cataract. The iPSC regenerative medicine product line contains HLCR011 and HLCR012. The products are in the preclinical testing and preparation for trial in Japan, which are candidate of regenerative medicine products. The products are iPS cell derived retinal pigment epithelium (RPE) cell suspension and sheet developed in Japan, United States and Europe.


PINL:HLOSF - Post by User

Post by The300on Feb 28, 2012 3:38pm
244 Views
Post# 19600145

MD&A

MD&A

Just finished reading MD&A on Sedar.  I know understand why we've been getting some buying pressure.  Looks like we will have a concurrent drilling programs on Sherridon and Red Lake which always helps to generate interest in anticipation of the results.  i imagine we slowly start to move up from here to the high teens simply based on the drill programs coming on line.

It looks like the company has been busy behind the scenes, however, unless they tell the world what they are doing, noone will care.  Most investors don't read MD&A, especially those not already invfested in the company.

The commencement of drill of programs is worthy of a press release and pretty standard practise for most companies.  it looks like the Red Lake program is already underway with Sherridon coming online shortly.

Market cap is under $4M with $2.5M in the bank and some decent land packages.  Too bad no one knows about it except existing shareholders.

As always, IMHO

The 30

 

<< Previous
Bullboard Posts
Next >>